US 9243068
Combination of SEMA-4D inhibitors and immunomodulators to inhibit tumors and metastases
granted A61KA61K2039/505A61K2039/507
Quick answer
US patent 9243068 (Combination of SEMA-4D inhibitors and immunomodulators to inhibit tumors and metastases) held by VACCINEX, INC. expires Mon Jan 21 2036 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- VACCINEX, INC.
- Grant date
- Tue Jan 26 2016 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Jan 21 2036 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 11
- CPC classes
- A61K, A61K2039/505, A61K2039/507, A61K2039/54, A61K2039/545